Publications by authors named "K Indrak"

Claim this Profile
I
Infectious complications of induction treatment for acute myeloid leukaemia using the "7 + 3" protocol without antibiotic prophylaxis - 15 years of experience of one clinical site.
Martin Cernan, Tomas Szotkowski, Jaromir Hubacek, Milan Kolar, Edgar Faber, Karel Indrak

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated erythroferrone distinguishes erythrocytosis with inherited defects in oxygen-sensing pathway from primary familial and congenital polycythaemia.
Lucie Sochorcova, Katarina Hlusickova Kapralova, Jana Fialova Kucerova, Dagmar Pospisilova, Daniela Prochazkova, Karel Indrak

Br J Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased blood reactive oxygen species and hepcidin in obstructive sleep apnea precludes expected erythrocytosis.
Jihyun Song, Krishna M Sundar, Monika Horvathova, Radhika Gangaraju, Karel Indrak

Am J Hematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of new technologies in myeloproliferative neoplasms: Application of next-generation sequencing in myelofibrosis.
Jana Navrátilová, Miroslava Palová, Tomáš Szotkowski, Antonín Hluší, Beáta Katrincsáková

Int J Lab Hematol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter.
Petra Belohlavkova, Katerina Steinerova, Michal Karas, Iva Skoumalova, Peter Rohon, Karel Indrak

Leuk Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis